These findings delineate a novel mechanistic cascade wherein luteolin exerts its therapeutic effect against CPP through activation of the Tlr3/Irf7/Stat1/Cxcl10– Cxcl11 axis. The gene discussed is CXCL11; the disease is central precocious puberty.